cephalosporin c has been researched along with Chronic Bronchitis in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balbisi, EA | 1 |
Aguilar, L; Alvarez-Sala, JL; Coronel, P; Kardos, P; Martínez-Beltrán, J | 1 |
Aguilar, L; Barberán, J; Coronel, P; Giménez, MJ; Gimeno, M; Granizo, JJ | 1 |
Anzueto, A; Bishai, WR; Pottumarthy, S | 1 |
Antón, N; Fernández-Sedand, L; Gómez-Garcés, JL; Ignacio Alós, J | 1 |
McCarty, JM; Pierce, PF | 1 |
Chyczewska, E; Grzelewska-Rzymowska, I; Haczyński, J; Malolepszy, J; Marcinkowska-Suchowierska, E; Milanowski, J; Oklek, K; Płusa, T; Rek, M; Szmygin, K; Słominski, J | 1 |
Dever, LL; Johanson, WG; Shashikumar, K | 1 |
4 review(s) available for cephalosporin c and Chronic Bronchitis
Article | Year |
---|---|
Cefditoren, a new aminothiazolyl cephalosporin.
Topics: Acute Disease; Bacterial Infections; Bronchitis, Chronic; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Interactions; Humans; Maxillary Sinusitis; Pharyngitis; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2002 |
The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clin
Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Administration Schedule; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Pneumonia, Bacterial; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Outcome | 2006 |
Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; beta-Lactamases; Bronchitis, Chronic; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Randomized Controlled Trials as Topic | 2007 |
Antibiotics in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Anti-Bacterial Agents; Bronchitis, Chronic; Cephalosporins; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Penicillins; Tetracyclines | 2002 |
3 trial(s) available for cephalosporin c and Chronic Bronchitis
Article | Year |
---|---|
Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
Topics: Acute Disease; Administration, Oral; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Cefuroxime; Cephalosporins; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; Haemophilus influenzae; Humans; Male; Middle Aged; Sputum; Time Factors; Treatment Outcome | 2006 |
Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefprozil; Cephalosporins; Clarithromycin; Demography; Double-Blind Method; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Treatment Outcome | 2001 |
Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis, Chronic; Cefaclor; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Single-Blind Method; Time Factors; Treatment Outcome | 2002 |
3 other study(ies) available for cephalosporin c and Chronic Bronchitis
Article | Year |
---|---|
[Therapeutic failure with ceftriaxone in a case of exacerbation of chronic bronchitis by pneumococcus highly resistant to beta-lactams].
Topics: Bronchitis, Chronic; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Treatment Failure | 2001 |
Antibiotic approval.
Topics: Bronchitis, Chronic; Cephalosporins; Drug Approval; Humans; Pharyngitis; United States; United States Food and Drug Administration | 2002 |
Spectracef. New cephalosporin antibiotic approved.
Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Cephalosporins; Drug Approval; Humans; Laryngitis; Staphylococcal Skin Infections; United States | 2002 |